跳至主要内容
临床试验/IRCT20120215009014N375
IRCT20120215009014N375尚未招募2 期

Effect of probiotic and zinc supplementation separately and in combination on reducing the complication of influenza-like syndrome during therapy by beta-interferon in patients with relapsing-remitting multiple sclerosis: a randomized clinical trial

Hamedan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 40 years(—)
性别
All

入选标准

  • Age: 20 to 40 years old
  • Relapsing-remitting multiple sclerosis
  • Corticosteroid therapy for at least 3 weeks

排除标准

  • Pregnancy or breastfeeding,
  • Receiving influenza vaccine
  • Respiratory infection in the past 2 weeks,
  • Using alcohol or opioid drugs in the past 2 months,
  • Autoimmune diseases or immunodeficiency syndrome,
  • Abdominal surgery,
  • Short bowel syndrome,
  • Mesenteric Ischemia,
  • History of tuberculosis or AIDS,
  • Liver or renal disease or diabetes or hypertension

研究者

相似试验